Cardinal Health, Inc. with ticker code (CAH) now have 14 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $134.00 and $94.00 with the average share target price sitting at $115.07. (at the time of writing). Now with the previous closing price of $102.91 and the analysts are correct then there would likely be a percentage uptick in value of 11.8%. The 50 day MA is $109.30 while the 200 day moving average is $100.15. The market capitalization for the company is 25.06B. The stock price for the company is currently is currently $103.04 USD
The potential market cap would be $28,024,177,185 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 40.89, revenue per share of $859.44 and a 2.79% return on assets.
Cardinal Health, Inc. is a globally integrated healthcare services and products company. The Company is focused on providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products and solutions. The Company’s segments include Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and patient management.
